BSEN 760
Alternative Names: BSEN-760Latest Information Update: 13 Feb 2024
At a glance
- Originator Bsense Bio Therapeutics
- Class Analgesics; Small molecules
- Mechanism of Action KCNQ2 potassium channel stimulants; KCNQ3 potassium channel stimulants; TRPV1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neuropathic pain; Pain